Objectives: To describe allergic asthma and allergic rhinitis pathophysiology and review the pharmacologic, pharmacokinetic, pharmacodynamic, efficacy, and safety data for omalizumab. Methods ...

The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...

Opens in a new tab or window The FDA approved omalizumab-igec (Omlyclo ... arm pain, pruritus, dermatitis, and earache were reported in at least 1% of patients. For asthma in children ages ...

"This is a 35 year old male with past medical history of asthma, atopic dermatitis, allergic rhinitis, gastroesophageal reflux, and food allergies presenting with severe asthma, not well ...

Discussions centered on mitigating the financial burden of pediatric atopic dermatitis through financial aid programs and enhancing support for young patients to independently manage their condition ...